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Summary Although EGF receptor expression is generally elevated in human lung squamous carcinoma, the
biological significance of this phenomenon and the role of EGF and TGF-a in this disease are poorly
understood. We have investigated three human lung squamous carcinoma cell lines (NX002, CX140 and
CX143) and have shown, using an antibody (EGFRI) directed against the EGF receptor, that the majority of
cells in all three lines express the EGF receptor. Using a ligand binding assay, Scatchard analysis indicated
high concentrations (1,300-2,700 fmol mg-' protein) of a single low affinity binding site (Kd = 3-5 nM)
within these lines. Addition of EGF or TGF-a at concentrations greater than 0.1 nm resulted in growth
inhibition of all three lines and this was associated with an accumulation of cells in the G2/M phase of the cell
cycle. Growth inhibitory effects were not explained by an enhancement of cellular differentiation as monitored
by involucrin expression and the ability to form cornified envelopes. While the presence of EGF could not be
detected in medium conditioned by the NX002 cell line, mRNA for TGF-a was detected in all three lines
suggesting the possibility of an autocrine loop. These results together with reports of growth inhibition by
EGF and TGF-a in other systems suggest that EGF and similar molecules might have a growth regulatory
role in lung cancer cells and modulation of such may have therapeutic potential.
The related molecules, epidermal growth factor (EGF) and
transforming growth factor-alpha (TGF-ax), modulate the
growth of a wide variety of normal and malignant cells
(reviewed in Burgess et al., 1989). Both factors operate
through the EGF receptor and in many malignant diseases,
for example lung squamous carcinoma, levels of the EGF
receptor are markedly overexpressed relative to normal tissue
(Hendler & Ozanne, 1984; Cerny et al., 1986; Berger et al.,
1987; Veale et al., 1987; Sobol et al., 1987; Dazzi et al.,
1989). The biological significance of this overexpression of
receptors in lung squamous carcinoma is not known. Cell
lines derived from human lung squamous carcinoma cell lines
have been shown to possess high concentrations of EGF
receptors (Haeder et al., 1988) and represent useful models to
study growth factor modulation. Little is known of the role
of EGF and TGF-x in this disease, however, several reports
have proposed that TGF-o may act in an autocrine manner
in this cell type (Lee et al., 1990; Putnam et al., 1991) while
another recent study has suggested that either EGF or TGF-
a might stimulate squamous differentiation (Levitt et al.,
1991).
In order to investigate further the role of EGF-like factors
in lung squamous carcinoma cells, we have developed cell
line models and have examined them for the presence of
EGF receptors. Two approaches have been used to detect
and measure the levels of this receptor: immunocytochemical
staining using an antibody directed against the receptor and
a competitive binding assay employing radiolabelled EGF.
We have also studied the effects of EGF and TGF-oc on the
growth characteristics of these lines by examining changes in
cell number and in the cell cycle distribution after exposure
to these agents. The possibility that these factors induce
differentiation within these cells was examined and finally, we
have looked for the expression of EGF protein and TGF-a
mRNA as an indication that these factors might exert con-
trol via an autocrine pathway.
Materials and methods
Cell lines
The human lung squamous carcinoma cell lines NX002,
CX140 and CX143 were established and characterised as
previously described (Rabiasz et al., 1991). They were main-
tained routinely at 37TC in a humidified atmosphere of 5%
CO2 in air in RPMI 1640 (Gibco) containing 5% heat-
inactivated foetal calf serum (FCS) and supplemented with
Streptomycin (100 jig ml-'), Penicillin (100 IU ml-') and glu-
tamine (2 mM).
Immunocytochemical detection ofEGF receptor and involucrin
The presence of EGF receptors and involucrin were detected
using an immunoperoxidase method employing avidin-bio-
tinylated horseradish peroxidase complex. The murine mono-
clonal antibody EGFR1, which was raised against the A431
cell line (Waterfield et al., 1982) was kindly supplied by Dr
W. Gullick, ICRF, London. Rabbit anti-involucrin was a gift
from Dr F. Watt, ICRF, London.
For detection of the EGF receptor, cells were trypsinised,
washed with serum-free RPMI 1640, and placed onto multi-
spot slides [Hendley (Essex) Ltd, Essex, UK] at approx-
imately 2 x 104 cells/spot. Cells were fixed in acetone:
methanol (1:1) for 5 min and stored at -20°C until use.
Slides were thawed and incubated for 10 min at room
temperature with 3% hydrogen peroxide to block endo-
genous peroxide activity. The slides were then washed in
0.05 M Tris Buffer (TB), pH 7.6 and incubated with rabbit
serum (Dako) in TB (1:5) for 20 min followed by incubation
with the mouse monoclonal antibody (EGFR1 1:100) for
30 min. A further wash in TB was followed by incubation for
30 min with biotinylated rabbit anti-mouse immunoglobulin
(Dako) diluted in TB (1:200). After washing, AB complex
was applied to cells and left for 30 min. A final TB wash was
given before peroxidase was localised using a fresh 1 mg ml- '
mixture of 3,3 diaminobenzidine tetrahydrochloride (DAB)
and 0.01% hydrogen peroxide in Tris imidazole buffer,
pH 7.6 for 10 min. After washing with water, cells were
counterstained with hematoxylin and scored for the presence
and intensity of positive staining by 2 or 3 independent
readers. The vulval carcinoma cell line, A431, which is
known to overexpress EGF receptors (Haigler et al., 1978)
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was used as a positive control and the small cell lung cancer
cell line, H69, known to lack EGF receptors (Gamou et al.,
1987) was used as a negative control. Additionally TB was
included in each staining run as a negative control and the
monoclonal antibody CAM 5.2 which reacts against cyto-
keratin as a positive control.
For detection of involucrin, cells growing on plastic and
exposed for 4 days to either EGF (10 nM), 12-O-tetra-
decanoylphorbol acetate (10 nM) or the above-described med-
ium containing 5% FCS were harvested by trypsinisation and
placed onto multispots. The above immunoperoxidase stain-
ing technique was then used with the following substitutions
- normal rabbit serum was replaced by normal porcine serum
(Dako) and biotinylated rabbit anti-mouse immunoglobulin
was replaced by biotinylated swine anti-rabbit antibody
(Dako; diluted 1:300 in TB).
Measurement ofEGFreceptors by ligand binding
Cells were grown to confluence in 175 cm2 flasks and washed
twice in PBS before being harvested by scraping. Cells were
disrupted in ice-cold Tris Buffered Saline, pH 7.4 (TBS) using
a sonicator and centrifuged at 105,000g for 30 min at 4°C
and resuspended in TBS. An aliquot was removed, and the
protein concentration estimated using the method of Brad-
ford (1976). Cell preparations (100 tl were incubated with
unlabelled EGF (200jil; 0-300 nM) and '251I-EGF (100Il;
0.02 nM = 10,000 c.p.m.) to give a final reaction volume of
400 gl for 90 min at 26°C. The reaction was terminated by
the addition of ice-cold 0.5% (w/v) IgG, followed by mixing
and addition of 25% (w/v) polyethylene glycol. After further
mixing, the bound and free '25I-EGF were separated by
centrifugation. The supernatant containing the free compo-
nent was aspirated, and the remaining pellet counted in a
Packard Multi-Prias Gamma Counter. The data was
analysed by the method of Scatchard (1949). The plots were
then examined by the computer analysis method of Hether-
ington to assign, fit and calculate both the slopes and
intercepts of the components (Nicholson et al., 1989; Sains-
bury et al., 1985).
Effect ofEGF and TGF-a on the growth ofthe cell lines
Exponentially growing cells were harvested by trypsinisation
and plated in 24-well plates (Falcon) at densities of approx-
imately 2 x 104 cells/well (four wells per experimental condi-
tion) in RPMI 1640 (Gibco) containing 5% FCS. After 48 h,
medium was removed and cells were washed with PBS.
Human recombinant EGF (hEGF; ICN) or TGF-x (Boer-
hinger) were added at concentrations ranging from 0.001 nM
to 10 nM in RPMI 1640 containing 5% FCS. This time point
was designated day 0. Media containing EGF or TGF-a was
replenished on days 2 and 5. On days 0, 2, 5 and 7, cells were
harvested and counted using a Coulter Counter.
To examine growth in serum-free conditions, cells were
plated into 24-well plates as described above and medium
changed after 24 h to RPMI 1640 with hydrocortisone (10
nM), insulin (5jg ml-), transferrin (10tgml-') and sodium
selenite (30 nM). After a further 24 h, growth factors were
added in the same medium and the experiment conducted as
described above for serum containing medium.
Cornified envelope competence assay
The competence of cells to form cornified envelopes was
determined essentially according to the method described by
Rice and Green (1979). Semi-confluent cultures were treated
for 4 days with either TPA (10 nM) or EGF (10 nM) in RPMI
1640 containing 5% serum or with this medium alone. Cells
were trypsinised, washed twice with RPMI 1640 medium and
resuspended at a density of 106 cells ml-' in the same
medium with or without 0.8 M NaCl for 4 h at 37°C to assay
envelope competence. Cell suspensions in phosphate buffered
saline containing 2% sodium dodecyl sulphate and 20 mM
P-mercaptoethanol were boiled for 2 min. Cornified envelopes
surviving this treatment were observed in a haemocytometer
chamber using a microscope.
Effect ofEGF and TGF-c on cell cycle distribution
Cells were plated at appropriate densities in 6-well plates as
described above. On day 0, cells were fed with media in the
presence or absence of EGF or TGF-a (0.1 nM and 10nM).
Cells were harvested after 48 and 72 h. Samples of approx-
imately 106 cells were prepared from quadruplicate wells at
each time point. Cells were treated with trypsin/detergent and
the DNA stained with propidium iodide (Vindelov et al.,
1983). Analysis was performed using a FACScan flow cyto-
meter (Becton Dickinson) equipped for doublet discrimina-
tion using Cellfit software. All data was gated on forward
and side scatter signals to exclude fragmented and clumped
material, and on a fluorescence width versus fluorescence
area signal to exclude doublets.
Radioimmunoassayfor EGF
The presence of immunoreactive hEGF in conditioned med-
ium from NX002 cells was investigated using liquid phase
competitive radioimmunoassay as described by McDonald et
al. (1990). Antiserum to EGF (raised in sheep to purified
hEGF) was a kind gift from Dr F. Habib, Western General
Hospital, Edinburgh. Medium (50 ml of RPMI 1640 contain-
ing 5% FCS) was conditioned by 2 x 107 confluent NX002
cells over a 48 h period, concentrated 100-fold by freeze-
drying and dialysed against PBS. Antiserum to hEGF was
incubated with '25I-EGF and either EGF (range: 0.2-200
ngml-') or conditioned medium for 2 h at 37°C. Anti-sheep
IgG (SAPU, UK) was added, incubated overnight at 4°C,
and precipitated by centrifugation at 2,000g for 30min at
4°C. The bound fraction was counted in a Packard gamma
counter and results computed using Packard's Cobra QC
curvefit analysis.
mRNA extraction
Exponentially growing cells were harvested from 175 cm2
culture flasks as follows: Cells were washed with ice cold
PBS, harvested using a cell scraper, suspended in 25 ml ice
cold PBS and spun down in a bench top centrifuge (1,000g,
10min). The cell pellet was stored at - 70°C until used for
RNA extraction. Using a sterile pasteur pipette the cell pellet
was transferred to a 15 ml tube containing 6 ml 3 M lithium
chloride/6 M urea. The homogenate was sonicated twice at
4°C for 30 s and stored overnight at 4°C. The pellet was spun
down at 15,000g, 4°C for 30 min. The supernatant was
discarded and the pellet washed with 6 ml fresh lithium
chloride/urea and centrifuged at 15,000g 4°C for 30 min. The
pellet was then resuspended in 6 ml 10 mM Tris-HCl (pH 7.5)
0.5% SDS, 50,ugml1' proteinase K (Boehringer Mannheim) added and the sample incubated at 37°C for 20 min. Follow-
ing incubation the samples were extracted using 100% phenol
(pre-equilibrated with 0.1 M Tris pH 7.4), this extraction was
repeated using phenol:chloroform, isoamyl-alcohol (25:24:1
v/v/v) and chloroform/isoamyl-alcohol (24:1 v/v). Following
each extraction the sample was centrifuged at 2,000g at
room temperature for 10 min and the aqueous phase re-
covered. After the final extraction, 300p1 8 M lithium
chloride and 2.5 volumes of absolute alcohol were added and
the RNA precipitated overnight at - 20°C. RNA was pel- leted by centrifugation at 4,000g, 4°C for 45 min. The super-
natant was decanted and the pellet dried and resuspended in
diethylpyrocarbonate treated water, optical density measure-
ments at 260 and 280 nm were taken to assess yield and
purity of the RNA preparation.
Synthesis ofriboprobes
Labelled RNA was prepared from linearised template DNA
using a Gemini II system (Promega Ltd, Southampton, UK).
Template DNA was incubated in the presence of an RNAse256 G.J. RABIASZ et al.
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Figure 1 Scatchard plot analysis of '25I-EGF binding to particulate fractions of the NX002 and A431 cell lines. For the NX002
cell line a single binding affinity component with a Kd value of 3.3 nm representing 1,275 fmol mg-' protein was observed. For the
A431 cell line, two components were observed with Kd values of 5.3 and 0.2 nm with receptor concentrations of 7,718 and
277 fmol mg-' protein respectively.
inhibitor (Human placental RNAsinI; Amersham plc), cold
ribonucleosides, dithiothreitol and 32P-rCTP with the appro-
priate RNA polymerase (T3, T7 or SP6) for 1 h at 37'C.
Following this incubation, the DNA template was removed
by incubation with RQ1 DNase (Promega Ltd) for 15 min at
37°C. Labelled RNA was precipitated in the presence of
added tRNA (Sigma) as carrier and full length transcripts
were isolated by polyacrylamide electrophoresis. Following
identification of full length transcripts by autoradiography,
the bands were excised and labelled RNA eluted from the
gel, precipitated under ethanol and resuspended in hybridisa-
tion buffer prior to use in RNAse protection assays.
RNAse protection assay
Test RNA (20jig) was precipitated under ethanol, dried and
resuspended in 30 jil hybridisation buffer (80% formamide,
40 mM Pipes (pH 6.7), 400 mM NaCl, 1 mM EDTA), tRNA
was prepared in a similar manner as a negative control. Test
probe (106 c.p.m.) plus actin probe (106 c.p.m.) were added to
each sample. Samples were incubated at 85'C for 20 min and
transferred to a water bath and left to hybridise overnight at
51°C.
Following hybridisation, single stranded RNA (both label-
led and cold) was removed by incubating with single strand
specific RNAses A and TI (Boehringer Mannheim) at 37'C
for 30 min, followed by incubation with proteinase K in SDS
at 37'C for 15 min. Protein was extracted by using phenol/
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chloroform-isoamyl alcohol. Double stranded probe:test
RNA was precipitated with carrier tRNA (5 jg) and separ-
ated by gel electrophoresis. Full length transcripts for test
probes were scored as positive, whilst transcripts for actin
were used as an internal control.
Results
The presence of EGF receptors within the three cell lines was
demonstrated by immunocytochemical staining and by use of
a '25I-EGF ligand binding assay (Figure 1). The majority of
cells in all three cell lines reacted with the EGFR1 antibody
as did the A431 cell line which is known to express high
levels of EGF receptor. Positive cells stained intensely. The
H69 cell line, known to not possess receptors, was negative.
The concentration of receptors was measured by Scatchard
analysis of the binding of '25I-EGF to particulate prepara-
tions. The lung cell lines demonstrated high receptor con-
centrations of between 1,300 and 2,700fmolmg-' protein.
Scatchard analysis indicated the presence of a single class of
binding sites for all three cell lines with Kd values of 3 to
5 nM. A typical Scatchard plot for the NX002 cell line is
shown in Figure la. In contrast, A431 cells demonstrated a
biphasic curve indicating the presence of two types ofbinding
sites with different affinities for EGF (Figure lb). The
majority of receptors in these cells possessed a Kd value of
5 nM, while a small minority had a higher affinity for EGF
120
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Figure 2 Effects of EGF and TGF- o on the growth of the cell lines. Cells were exposed to factors for 7 days with media being
replenished on days 2 and 5. Cell numbers relative to those in control cultures (without growth factor) are shown and represent the
mean ± standard deviation of four values. For the experiments shown, the change in cell number between Day 0 and Day 7 for the
untreated groups were as follows: 7.7-fold for NX002; 8.4-fold for CX140 and 9.1-fold for CX143.EGF-LIKE FACTORS IN LUNG SQUAMOUS CARCINOMA 257
(Kd = 0.2 nM), a result consistent with previous reports
(Kawamoto et al., 1983).
The effect of a 7-day exposure of EGF and TGF-a on the
growth of the lung cell lines is shown in Figure 2. Both EGF
and TGF-a inhibited growth of the cell lines in a dose-
dependent fashion at concentrations greater than 0.1 nM. The
level of inhibition is similar between the cell lines and both
EGF and TGF-oa produced equivalent effects. Cell counts
were also performed after 2 and 5 days exposure to the
factors and inhibition was also seen at these time points (data
not shown). EGF was equally effective in serum-free as in
serum-containing medium (Figure 3).
The influence of EGF and TGF-ca on the cell cycle dist-
ribution of the cell lines was studied. After a 48 h exposure
to either EGF or TGF-a at 1 or 10 nM, cells in all three lines
began accumulating in the G2,/M phase of the cell cycle with
a consequent reduction in the percentage of cells in GO GI
(Figure 4). Both concentrations of factor produced similar
effects. Similar changes were observed at 72 h (data not
shown).
EGF (10 nM) produced changes in the appearance of
NX002 cells with increased spreading on the plastic substrate
(Figure 5). Multinucleation could be seen in many cells con-
sistent with cells accumulating at the G2 M phase (Figure 5).
The possibility that growth inhibition by EGF was related to
an enhancement in differentiation was examined by inves-
tigating the percentage of cells expressing the differentiation
marker involucrin and the percentage of cells competent to
form cornified envelopes after exposure to 10 nM EGF.
Under conditions in which a known inducer (12-O-tetrade-
canoylphorbol acetate) increased the percentage of cells ex-
pressing involucrin or competent to form cornified envelopes.
EGF did not produce a significant change (Figure 6).
Since the cell lines express EGF receptors and respond to
addition of exogenous factors, it is feasible that the factors
might operate in an autocrine fashion within these cell lines.
Using an RNAse protection assay, the expression of an
mRNA transcript was detected within these lines at approx-
imately 1,050 base pairs consistent with the length of tem-
plate DNA used to synthesise the complementary probe for
TGF-a (Figure 7). By radioimmunoassay, EGF could not be
detected within medium conditioned by the NX002 cell line
(limit of detection = 0.2 ng ml-').
Discussion
The lung squamous carcinoma cell lines described in this
report contain high concentrations of EGF receptors as dem-
onstrated by a ligand binding assay. These values of
1,300-2,700 fmol mg-' protein are higher but comparable to
the values previously reported by Haeder et al. (1988) for
four other cell lines of the same histology in which maximum
binding values varied from 500-600 fmol mg-' protein and
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Figure 3 Effect of EGF on the growth of the NX002 cell line in
serum-containing and serum-free conditions. Cells were exposed
to EGF at the concentrations shown for 7 days with media and
factor being replenished on days 2 and 5. Cell numbers relative to
those in control cultures (without added EGF) are shown and
represent the mean + standard deviation of four values. For the
experiments shown the change in cell number between Day 0 and
Day 7 for the untreated groups were 8.6-fold for the 5% serum-
containing group and 10.5-fold for the serum free group.
Kd values from 1-3 nM. Only a single low affinity binding
population (Kd = 3-5 nM) could be deduced from the straight
line plots obtained for our lung lines while two populations
of receptor could be identified from the biphasic curve
obtained in the Scatchard analysis for the A431 cell line.
Addition of nanomolar concentrations of EGF or TGF-a
inhibited growth of the three lung carcinoma cell lines. This
is consistent with data from squamous cell lines of other
histologies, such as A431 cells, where EGF, when added at
nanomolar concentrations, is inhibitory to systems showing
very high concentrations of the EGF receptor although, if
added at picomolar concentrations, EGF can be stimulatory
(Gill & Lazar, 1981; Barnes, 1982; Filmus et a!., 1985;
Kamata et al., 1986). In several studies the level of inhibition
has been shown to increase as the EGF receptor number
increases (Kamata et al., 1986; Kawamoto et a!., 1984).
Detailed studies of the A431 cell line, employing clonal
xariants and using antibodies with different specificities for
the high and low affinity EGF binding sites, have suggested
that the low affinity receptor in A431 cells (which accounts
for > 99%0 EGF binding at nM concentrations) is responsible
for growth inhibition while the high affinity site (accounting
for about 0.1% binding) is associated with growth stimula-
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Figure 4 Effect of EGF on the cell cycle distribution. Cells were exposed to EGF (I or 10 mM) for 48 h. Values are shown as
mean ± standard deviation of four determinations. * Values are statistically different from control (P<0.05) using a Mann-
Whitney test.258 G.J. RABIASZ et al.
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Figure 5 Photomicrograph of NX002 cells ( x 250) either un-
treated a, or treated with 10 nM EGF for 4 days b. A substantial
proportion of multinucleated cells can be observed after exposure
to EGF.
tion at pM levels of EGF or TGF-x (Kawamoto et al., 1983,
1984; Gill et al., 1984). Therefore the absence of high affinity
binding sites in the lung carcinoma lines might explain a lack
of stimulation at picomolar concentration of factors.
After exposure of these cell lines to EGF or TGF-x, cells
accumulated in the G2/M phase of the cell cycle. This is
consistent with the blockade of A431 cells in the G2 phase of
the cell cycle as reported by MacLeod et al. (1986) but
contrasts with the stimulatory effects of EGF wherein the
proportion of cells in the G2/M phase also increases.
The possibility that the change of appearance and growth
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Figure 6 Effect of EGF on markers of differentiation within the
NX002 cell line. The percentage of cells positive for involucrin
( M ) or competent to form cornified envelopes ( _ ) after 4
days exposure to either 1OnM EGF or 1OnM TPA or medium
alone are shown as mean values ± standard error of four inde-
pendent determinations.
inhibition of these lines by EGF was related to enhanced
differentiation was investigated but there was no increase in
the percentage of cells expressing the differentiation-related
marker involucrin or in the ability to produce cornified
envelopes. EGF has been shown to have a variety of effects
on squamous carcinoma systems including both promotion
(Levitt et al., 1991) and inhibition of differentiation (Reiss &
Sartorelli, 1987) while others have shown no effect (Ponec et
al., 1988).
Although the secretion of EGF by these cell lines could
not be detected by radioimmunoassay, the presence of TGF-
a mRNA could be demonstrated. TGF-o mRNA and TGF-a
protein have been identified in at least 2 other lung squamous
carcinoma cell lines (Soderdahl et al., 1988; Lee et al., 1990)
while experiments using blocking antibodies to TGF-a have
resulted in growth modulation of this cell type (Levitt et al.,
1991).
In conclusion, these results indicate that both EGF and
TGF-a are growth inhibitory to lung squamous carcinoma
cells expressing high levels of low-affinity binding receptors.
Since TGF-a is also expressed by these cell lines, these data
lends support to the hypothesis that this factor may play an
autocrine role in this disease and modulation of such may
have therapeutic potential.
Figure 7 6% Polyacrylamide gel showing bands representing mRNA for TGF-a and human y-actin. Lane 1 contains 35S-labelled
molecular weight markers. Lanes 2 and 3 contain untreated riboprobes for y-actin and TGF-a. Lane 4 contains tRNA as a negative
control. Lane 5-7 contain samples from the cell lines.EGF-LIKE FACTORS IN LUNG SQUAMOUS CARCINOMA 259
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